Xeber.world
Biogen’s experimental Alzheimer’s drug diranersen reduced tau levels in early-stage patients and slowed cognitive decline in a Phase 2 trial. Meanwhil...
The pharmaceutical industry is calling for the next FDA commissioner to restore stability after months of turmoil, including leadership changes and st...
Pharmaceutical companies backing TrumpRx spent over $130 million on federal lobbying in 2025, a 23% surge. Eli Lilly paused its obesity awareness camp...
President Donald Trump's second term has seen multiple initiatives to reduce prescription drug costs, but results are mixed. While some prices dropped...
Novo Nordisk’s new weight-loss pill, Wegovy, has achieved 1.3 million prescriptions in Q1 2026, prompting the company to raise its full-year guidance....
A new survey reveals that 57% of patient groups rated pharmaceutical companies' reputation as 'excellent' or 'good' in 2025, up from 56% in 2024. Whil...
Supreme Court justices heard arguments on the legality of 'skinny labeling,' a tactic used by generic drugmakers to avoid patent infringement lawsuits...
Novartis CEO Vas Narasimhan warns that President Trump's most-favored-nation drug pricing policy could disrupt global drug access and delay new treatm...
Intellia Therapeutics reported that a single dose of its CRISPR-based gene editing therapy, lonvo-z, dramatically reduced swelling attacks in a Phase...
Kelonia Therapeutics, a CAR-T biotech on the brink of collapse three times, was acquired by Eli Lilly for $3.25 billion. The deal highlights the secto...
Sanofi's research priorities are under review as new CEO Belén Garijo begins her tenure. The company's recent focus on immunology has yielded lacklust...
Health policy experts and legislators are raising concerns over high fees paid by pharmaceutical companies to telehealth providers, potentially violat...
Purdue Pharma faces a $225 million forfeiture in an opioid settlement, while Pfizer’s chief strategy officer Andrew Baum exits after just months in th...
Alfred Engelberg, a patent lawyer, played a pivotal role in shaping U.S. pharmaceutical policy. His work led to more generic drugs but also entrenched...